Variables | Disease recurrence | p-value | Total (n = 690) | |
---|---|---|---|---|
Yes (n = 234) | No (n = 456) | |||
Hospital length of stay, days | ||||
Median (IQR) | 7.5 (6–11) | 7 (5–10) | < 0.05 | 7 (5–10) |
Mean (SD) | 9.5 (6.6) | 8.5 (5.5) | < 0.05 | |
Age, median (min-max) | 70 (25–93) | 71 (19–92) | NS | 71 (19–93) |
Gender,n(%) | ||||
Female | 121 (52) | 254 (56) | NS | 375 (54) |
Male | 113 (48) | 202 (44) | 315 (46) | |
Surgery,n(%) | ||||
Open | 205 (88) | 380 (83) | NS | 585 (85) |
Laparoscopic | 29 (12) | 76 (17) | 105 (15) | |
Tumor location,n(%) | ||||
Right sided | 121 (52) | 247 (54) | NS | 368 (53) |
Left sided | 110 (47) | 203 (45) | 313 (45) | |
Multiple locations | 3 (1) | 6 (1) | 9 (1) | |
Differentiation grade,n(%) | ||||
Low grade (G1–G2) | 161 (69) | 322 (71) | NS | 483 (70) |
High grade (G3–G4) | 59 (25) | 109 (24) | 168 (24) | |
Mucinous | 14 (6) | 25 (5) | 39 (6) | |
Number of positive lymph nodes, median (IQR) | 3.5 (2–6) | 2 (1–4) | < 0.01 | 2 (1–5) |
T-stage,n(%) | ||||
1 | 0 (0) | 10 (2) | < 0.01 | 10 (1) |
2 | 8 (3) | 36 (8) | 44 (6) | |
3 | 164 (70) | 323 (71) | 487 (71) | |
4 | 62 (27) | 87 (19) | 149 (22) | |
N-stage,n(%) | ||||
N1 | 117 (50) | 329 (72) | < 0.01 | 446 (65) |
N2 | 117 (50) | 127 (28) | 244 (35) | |
ACCI,n(%)a | ||||
0–2 | 84 (36) | 178 (39) | NS | 262 (38) |
3–5 | 137 (59) | 239 (52) | 376 (54) | |
6–9 | 13 (6) | 39 (9) | 52 (8) | |
Clavien-Dindo,n(%) | ||||
0–3a | 216 (92) | 428 (94) | NS | 644 (93) |
3b–4 | 18 (8) | 28 (6) | 46 (7) | |
Readmission,n(%) | ||||
No | 219 (94) | 424 (93) | NS | 643 (93) |
Yes | 15 (6) | 32 (7) | 47 (7) |